Laser welding an alternative to sutures

Article

A study published in the September issue of the Journal of Cataract and Refractive Surgery suggests that a laser welding technique could offer a good alternative to suturing for closing corneal wounds following phaco or extracapsular cataract extraction.

A study published in the September issue of the Journal of Cataract and Refractive Surgery suggests that a laser welding technique could offer a good alternative to suturing for closing corneal wounds following phaco or extracapsular cataract extraction.

Luca Menabuoni and co-workers from the Hospital of Misericordia e Dolce, Prato, Italy used a diode laser to weld the stroma after cataract surgery in 20 eyes of 20 patients. All eyes had a preoperative visual acuity (VA) of 20/200 or worse.

No wound leakage was noted in any of the eyes during follow-up and endothelial cell loss rates were similar to those you would expect following standard cataract surgical procedures. No collateral effects or postoperative inflammation was detected in any of the eyes. However, nine of the ten eyes that underwent extracapsular cataract extraction demonstrated slight differences between pre- and postoperative levels of astigmatism.

It was concluded that the laser-assisted procedure has potential as a method for closing longer incisions.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.